COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma
Erik Gaitzsch(Ludwig-Maximilians-Universität München), Oliver Weigert(German Cancer Research Center), Kilian Schober(Friedrich-Alexander-Universität Erlangen-Nürnberg), Marion Subklewe(LMU Klinikum), Hans‐Joachim Stemmler(Ludwig-Maximilians-Universität München), Andreas Osterman(German Center for Infection Research), Clemens Scherer(LMU Klinikum), Michael Heide(German Primate Center), Stephanie-Susanne Stecher(LMU Klinikum), Alexandra Leutbecher(LMU Klinikum), Michael von Bergwelt‐Baildon(German Cancer Research Center), Philipp Girl(Universität der Bundeswehr München), Carolin Dorothea Strobl(Friedrich-Alexander-Universität Erlangen-Nürnberg), Juliane Kager(TUM Klinikum), Elham Khatamzas(Humboldt-Universität zu Berlin), Roman Wölfel(Universität der Bundeswehr München), Enrico Georgi(Universität der Bundeswehr München), Laura M. Mateyka(Institute of Medical Microbiology and Hygiene), Michael Quante(German Cancer Research Center), Tobias Weiglein(Ludwig-Maximilians-Universität München), Roman Iakoubov(TUM Klinikum), Anna Reischer(LMU Klinikum), Matthias Treiber(TUM Klinikum), Christoph D. Spinner(TUM Klinikum), Martin Dreyling(LMU Klinikum), Adrian Ruhle(LMU Klinikum), Benjamin Tast(Ludwig-Maximilians-Universität München), Dirk H. Busch(German Center for Infection Research), Johannes C. Hellmuth(German Cancer Research Center), Tobias Lahmer(TUM Klinikum), Jürgen Ruland(Technical University of Munich), Maximilian Muenchhoff(German Center for Infection Research), Jochen Schneider(TUM Klinikum), Oliver T. Keppler(German Center for Infection Research), Christof Winter(TUM Klinikum), Sebastian Rasch(TUM Klinikum), Elvira D’Ippolito(Fondazione IRCCS Istituto Nazionale dei Tumori), Ulrike Protzer(German Center for Infection Research), Verena Passerini(Center for Integrated Protein Science Munich)
Cited by 54
Related Papers
Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2013|1.7k
PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma
|New England Journal of Medicine|2014|1.1k
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
|European Journal of Immunology|2019|1k